Is this presentation demand (supply‑demand) ischemia or type 2 myocardial infarction?

Distinguishing Demand Ischemia from Type 2 MI

Type 2 MI and demand ischemia are the same entity—both describe myocardial injury from oxygen supply-demand mismatch without atherothrombosis—but the term "Type 2 MI" should only be used when there is objective evidence of acute myocardial ischemia (ECG changes, imaging abnormalities, or angiographic findings) in addition to elevated troponins, whereas "demand ischemia" or "myocardial injury" applies when troponins are elevated without such objective ischemic features 1, 2.

The Critical Distinction

The 2025 ACC/AHA guidelines and Fourth Universal Definition clarify that Type 2 MI requires both:

1. Cardiac biomarker elevation (troponin >99th percentile with rise/fall pattern)
2. Clinical evidence of acute myocardial ischemia from supply-demand imbalance unrelated to coronary atherothrombosis 1, 2

What Constitutes "Clinical Evidence of Ischemia"?

Objective features that distinguish Type 2 MI from simple myocardial injury include 3:

• ECG changes: ST-segment depression, T-wave inversion, or new conduction abnormalities
• Imaging evidence: New regional wall motion abnormalities on echocardiography or cardiac MRI showing acute ischemia
• Angiographic findings: Evidence of supply-demand mismatch without plaque rupture

Recent validation studies demonstrate that patients with "objective Type 2 MI" (those with ECG/imaging evidence) have dramatically worse outcomes than those with "subjective Type 2 MI" (symptoms and troponin elevation alone), with 17% vs 2% in-hospital mortality respectively 3. This suggests that troponin elevation with ischemic symptoms alone should be classified as myocardial injury rather than Type 2 MI unless objective ischemic features are present.

Algorithmic Approach to Classification

Step 1: Confirm Myocardial Injury

• Troponin >99th percentile with rise/fall pattern (≥20% change) 2

Step 2: Identify the Precipitating Condition

Common triggers of supply-demand mismatch 4, 5:

• Increased demand: Tachyarrhythmias (especially supraventricular), sustained severe hypertension, thyrotoxicosis
• Decreased supply: Anemia, hypotension/shock, respiratory failure/hypoxemia, coronary vasospasm
• Combined: Sepsis (most common overall cause at 24%), severe stress

Step 3: Look for Objective Ischemic Evidence

If present → Diagnose as Type 2 MI:

• New ST-segment depression or T-wave inversions
• New regional wall motion abnormalities on imaging
• Angiographic evidence of supply-demand mismatch

If absent → Classify as myocardial injury or "demand ischemia":

• Troponin elevation with precipitating condition
• Ischemic symptoms alone (without ECG/imaging changes)
• This carries significantly better prognosis 3

Common Pitfalls to Avoid

1. Don't diagnose Type 2 MI based solely on symptoms and troponin elevation: The 2023-2025 data strongly suggest this overdiagnoses Type 2 MI and misses the prognostic importance of objective ischemia 3

2. Don't confuse Type 2 MI with Type 1 MI: Type 1 involves atherosclerotic plaque rupture/thrombosis; Type 2 has no acute coronary atherothrombosis 1, 2

3. Don't assume all troponin elevations in sick patients are Type 2 MI: Many represent myocardial injury without ischemia (e.g., sepsis-induced myocardial depression without supply-demand mismatch)

4. Age and comorbidities matter: Elderly patients (median age 81 in stroke studies) and those with severe acute illness are more likely to have triggers but may not manifest classic ischemic ECG changes 5

Clinical Implications

The distinction matters for prognosis and management: Patients with objective Type 2 MI have 11-fold higher in-hospital mortality than those with myocardial injury alone and require more aggressive treatment of the precipitating condition 3. Those with myocardial injury without objective ischemia have outcomes similar to no myocardial injury and may not benefit from intensive coronary-directed therapies 3.

Treatment focuses on the precipitating condition 4, 6:

• Correct anemia with transfusion
• Control heart rate in tachyarrhythmias
• Manage blood pressure extremes
• Provide respiratory support for hypoxemia
• Treat sepsis/shock

Coronary evaluation should be individualized: Consider angiography if there's concern for underlying obstructive CAD that contributed to the supply-demand mismatch, particularly if objective ischemic features are present 1.